Home Millendo Therapeutics

Millendo Therapeutics

acquired
IPO Delisting
Developer of New Drugs for Endocrine Disease Treatment
Basic
Enterprise Profile
LinkedIn

Basic Information

Millendo Therapeutics is a biopharmaceutical company that was previously mainly focused on developing new therapies for endocrine diseases where current treatments are non-existent or insufficient. Millendo seeks to create unique and transformative treatments in areas of significant unmet medical need.
Millendo Therapeutics, Inc.
Michigan,United States of America
51~100 people
January 01, 2012
--

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Technology
Biotechnology
Concept
Department of Endocrinology Endocrine System Diseases Therapeutic Products
Application Scenarios
Innovative Drugs